Details for New Drug Application (NDA): 211263
✉ Email this page to a colleague
The generic ingredient in CASPOFUNGIN ACETATE is caspofungin acetate. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the caspofungin acetate profile page.
Summary for 211263
Tradename: | CASPOFUNGIN ACETATE |
Applicant: | Areva Pharms |
Ingredient: | caspofungin acetate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 211263
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 211263 | ANDA | UBI Pharma Inc. | 72843-434 | 72843-434-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72843-434-01) / 10.8 mL in 1 VIAL, SINGLE-DOSE |
CASPOFUNGIN ACETATE | caspofungin acetate | POWDER;INTRAVENOUS | 211263 | ANDA | UBI Pharma Inc. | 72843-533 | 72843-533-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72843-533-01) / 10.8 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 50MG/VIAL | ||||
Approval Date: | Oct 1, 2021 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 70MG/VIAL | ||||
Approval Date: | Oct 1, 2021 | TE: | AP | RLD: | No |
Complete Access Available with Subscription